Multiparametric MR-Guided High Dose Adaptive Radiotherapy With Concurrent Temozolomide in Patients With Newly Diagnosed Glioblastoma

NCT04574856 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

RADIATION: Dose-Intensified Radiotherapy
DRUG: Temozolomide
DRUG: Adjuvant temozolomide

Sponsor

University of Michigan Rogel Cancer Center